- Home
- MAC vs PLXS Comparison
MAC vs PLXS Comparison
Compare MAC & PLXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MAC | PLXS |
|---|---|---|
| Founded | 1964 | 1979 |
| Country | United States | United States |
| Employees | 2845 | 20000 |
| Industry | Real Estate Investment Trusts | Electrical Products |
| Sector | Real Estate | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 7.2B |
| IPO Year | 1994 | 1995 |
Fundamental Metrics
Financial Performance| Metric | MAC | PLXS |
|---|---|---|
| Price | $22.97 | $230.68 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 5 |
| Target Price | $26.63 | ★ $304.60 |
| AVG Volume (30 Days) | ★ 2.8M | 191.9K |
| Earning Date | 11-04-2026 | 10-28-2026 |
| Dividend Yield | ★ 2.94% | N/A |
| EPS Growth | 11.36 | ★ 56.11 |
| EPS | N/A | ★ 4.90 |
| Revenue | ★ $1,013,983,000.00 | N/A |
| Revenue This Year | N/A | $21.42 |
| Revenue Next Year | $5.98 | $14.96 |
| P/E Ratio | ★ N/A | $48.75 |
| Revenue Growth | ★ 10.43 | N/A |
| 52 Week Low | $16.03 | $132.03 |
| 52 Week High | $26.68 | $307.06 |
Technical Indicators
Market Signals| Indicator | MAC | PLXS |
|---|---|---|
| Relative Strength Index (RSI) | 52.54 | 30.40 |
| Support Level | $22.86 | $190.68 |
| Resistance Level | $25.97 | $297.13 |
| Average True Range (ATR) | 0.50 | 7.33 |
| MACD | 0.10 | -4.03 |
| Stochastic Oscillator | 70.13 | 1.34 |
Price Performance
Historical ComparisonAbout MAC Macerich Company (The)
Macerich invests in premium mall assets. The company owns 27 regional malls in its consolidated portfolio and 10 regional malls in its unconsolidated portfolio along with a power center and six other real estate assets. The company's total portfolio has 39.2 million square feet of gross leasable area and averaged $899 sales per square foot over the 12 months ended in March 2026.
About PLXS Plexus Corp.
Plexus Corp designs, manufactures, and services complex products in demanding regulatory environments, supporting life-saving medical devices, mission-critical aerospace and defense products, industrial automation systems, and semiconductor capital equipment. Its integrated lifecycle solutions span design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services for market and disruptive companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The Company operates through three reportable segments: AMER, APAC, and EMEA, with the majority of revenue from the APAC segment.